130 related articles for article (PubMed ID: 9292925)
21. LcrV synthesis is altered by DNA adenine methylase overproduction in Yersinia pseudotuberculosis and is required to confer immunity in vaccinated hosts.
Badie G; Heithoff DM; Mahan MJ
Infect Immun; 2004 Nov; 72(11):6707-10. PubMed ID: 15501808
[TBL] [Abstract][Full Text] [Related]
22. Structure and function of cytidine monophosphate kinase from Yersinia pseudotuberculosis, essential for virulence but not for survival.
Walker NJ; Clark EA; Ford DC; Bullifent HL; McAlister EV; Duffield ML; Acharya KR; Oyston PC
Open Biol; 2012 Dec; 2(12):120142. PubMed ID: 23271832
[TBL] [Abstract][Full Text] [Related]
23. First case of postaneurysmal prosthetic vascular infection due to a nonsuperantigenic Yersinia pseudotuberculosis strain.
Loïez C; Carnoy C; Decoene C; Pradel E; Fichel C; Courcol R; Wallet F
J Clin Microbiol; 2010 Aug; 48(8):3024-6. PubMed ID: 20573875
[TBL] [Abstract][Full Text] [Related]
24. The pyruvate-tricarboxylic acid cycle node: a focal point of virulence control in the enteric pathogen Yersinia pseudotuberculosis.
Bücker R; Heroven AK; Becker J; Dersch P; Wittmann C
J Biol Chem; 2014 Oct; 289(43):30114-32. PubMed ID: 25164818
[TBL] [Abstract][Full Text] [Related]
25. [The pathogenicity factors of Yersinia pseudotuberculosis and the pathogenetic aspects of pseudotuberculosis].
Timchenko NF
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):25-9. PubMed ID: 9432840
[No Abstract] [Full Text] [Related]
26. Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors.
Prehna G; Ivanov MI; Bliska JB; Stebbins CE
Cell; 2006 Sep; 126(5):869-80. PubMed ID: 16959567
[TBL] [Abstract][Full Text] [Related]
27. Galleria mellonella as an alternative infection model for Yersinia pseudotuberculosis.
Champion OL; Cooper IAM; James SL; Ford D; Karlyshev A; Wren BW; Duffield M; Oyston PCF; Titball RW
Microbiology (Reading); 2009 May; 155(Pt 5):1516-1522. PubMed ID: 19383703
[TBL] [Abstract][Full Text] [Related]
28. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
Monnazzi LG; Carlos IZ; de Medeiros BM
Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
[TBL] [Abstract][Full Text] [Related]
29. [Modern concepts on the relationship between the agents causing plague and pseudotuberculosis].
Kukleva LM; Protsenko OA; Kutyrev VV
Mol Gen Mikrobiol Virusol; 2002; (1):3-7. PubMed ID: 11904922
[TBL] [Abstract][Full Text] [Related]
30. YPTB3816 of Yersinia pseudotuberculosis strain IP32953 is a virulence-related metallo-oligopeptidase.
Atas A; Seddon AM; Ford DC; Cooper IA; Wren BW; Oyston PC; Karlyshev AV
BMC Microbiol; 2016 Nov; 16(1):282. PubMed ID: 27887582
[TBL] [Abstract][Full Text] [Related]
31. The biosynthesis and biological role of 6-deoxyheptose in the lipopolysaccharide O-antigen of Yersinia pseudotuberculosis.
Ho N; Kondakova AN; Knirel YA; Creuzenet C
Mol Microbiol; 2008 Apr; 68(2):424-47. PubMed ID: 18284593
[TBL] [Abstract][Full Text] [Related]
32. Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model.
Garrity-Ryan LK; Kim OK; Balada-Llasat JM; Bartlett VJ; Verma AK; Fisher ML; Castillo C; Songsungthong W; Tanaka SK; Levy SB; Mecsas J; Alekshun MN
Infect Immun; 2010 Nov; 78(11):4683-90. PubMed ID: 20823209
[TBL] [Abstract][Full Text] [Related]
33. Experimental infection of mice with Yersinia strains bearing or not bearing the virulence-associated plasmid.
Bauab TM; Falcão DP
Contrib Microbiol Immunol; 1991; 12():144-55. PubMed ID: 1935082
[No Abstract] [Full Text] [Related]
34. Pathogenic role of a superantigen in Yersinia pseudotuberculosis infection.
Abe J; Kano H; Nogami H; Matsumoto S; Baba K; Saito H; Kohsaka T
Adv Exp Med Biol; 2003; 529():459-61. PubMed ID: 12756809
[No Abstract] [Full Text] [Related]
35. [Genotyping of Yersinia pseudotuberculosis isolated in Siberia and Far East].
Chesnokova MV; Klimov VT; Maramovich AS
Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):20-5. PubMed ID: 17163133
[TBL] [Abstract][Full Text] [Related]
36. The Tat Substrate SufI Is Critical for the Ability of Yersinia pseudotuberculosis To Cause Systemic Infection.
Avican U; Doruk T; Östberg Y; Fahlgren A; Forsberg Å
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28115509
[TBL] [Abstract][Full Text] [Related]
37. [A study of the nucleotide sequence variability of rha locus genes of Yersinia pestis main and non-main subspecies].
Kukleva LM; Eroshenko GA; Kuklev VE; Shavina NIu; Krasnov IaM; Guseva NP; Kutyrev VV
Mol Gen Mikrobiol Virusol; 2008; (2):23-7. PubMed ID: 18488445
[TBL] [Abstract][Full Text] [Related]
38. Purification, characterization and cloning of a novel variant of the superantigen Yersinia pseudotuberculosis-derived mitogen.
Ramamurthy T; Yoshino K; Abe J; Ikeda N; Takeda T
FEBS Lett; 1997 Aug; 413(1):174-6. PubMed ID: 9287138
[TBL] [Abstract][Full Text] [Related]
39. A novel superantigenic exotoxin from Yersinia psuedotuberculosis and its position in the classification of the entire bacterial toxins.
Uchiyama T
Contrib Microbiol Immunol; 1995; 13():191-4. PubMed ID: 8833831
[No Abstract] [Full Text] [Related]
40. Far East Scarlet-Like Fever Caused by a Few Related Genotypes of Yersinia pseudotuberculosis, Russia.
Timchenko NF; Adgamov RR; Popov AF; Psareva EK; Sobyanin KA; Gintsburg AL; Ermolaeva SA
Emerg Infect Dis; 2016 Mar; 22(3):503-6. PubMed ID: 26889961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
